Can Monitoring of Intrathoracic Impedance Reduce Morbidity and Mortality in Patients with Chronic Heart Failure? Rationale and Design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF)
- 1 September 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 10 (9) , 907-916
Abstract
Background: Chronic heart failure is associated with frequent hospitalisations which are often due to volume-overload decompensation. Monitoring of intrathoracic impedance, measured from an implanted device, can detect increases in pulmonary fluid retention early and facilitate timely treatment interventions. Objective: The DOT-HF trial is designed to investigate if ambulatory monitoring of intrathoracic impedance together with other device-based diagnostic information can reduce morbidity and mortality in patients with chronic heart failure who are treated with cardiac resynchronization therapy (CRT) and/or an implantable defibrillator (ICD). Methods: Approximately 2400 patients will be randomised in a 1:1 fashion to a management strategy with access to the diagnostic information from the implantable device (“access arm”), or a “control arm”, where this information is not made available. Study subjects fulfil standard indications for CRT and/or ICD as outlined in current guidelines. In the access arm, a fluid alert algorithm is used to give early warning of decreasing intrathoracic impedance indicating a high risk of an impending volume-overload decompensation. The primary endpoint of DOT-HF is the composite of all-cause mortality or heart failure hospitalisation. Secondary and exploratory endpoints include all-cause mortality, the impact on total health care utilization, quality of life and cost effectiveness. The study is expected to close recruitment during 2010 and to report in 2012.Keywords
This publication has 41 references indexed in Scilit:
- Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart FailureJACC, 2008
- ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyEuropean Heart Journal, 2006
- Cardiac Resynchronization Therapy Improves Heart Rate Profile and Heart Rate Variability of Patients With Moderate to Severe Heart FailureJACC, 2005
- Evaluation and Monitoring of Patients with Acute Heart Failure SyndromesThe American Journal of Cardiology, 2005
- Monitoring of Physical Activity and Heart Rate Variability in Patients With Chronic Heart Failure Using Cardiac Resynchronization DevicesThe American Journal of Cardiology, 2005
- Cardiac Resynchronization Therapy Improves Heart Rate Variability in Patients with Symptomatic Heart FailureCirculation, 2003
- Ongoing right ventricular hemodynamics in heart failureJACC, 2003
- Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?European Heart Journal, 2001
- Survival of patients with a new diagnosis of heart failure: a population based studyHeart, 2000
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990